Sakiko Sanada

639 total citations
29 papers, 501 citations indexed

About

Sakiko Sanada is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Sakiko Sanada has authored 29 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Sakiko Sanada's work include Endometrial and Cervical Cancer Treatments (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Sakiko Sanada is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Sakiko Sanada collaborates with scholars based in Japan, United States and Sri Lanka. Sakiko Sanada's co-authors include Hirohisa Yano, Jun Akiba, Sachiko Ogasawara, Masamichi Nakayama, Rin Yamaguchi, Kosuke Ueda, Reiichiro Kondo, Yoshiki Naito, Osamu Nakashima and Hironori Kusano and has published in prestigious journals such as PLoS ONE, Acta Biomaterialia and The American Journal of Surgical Pathology.

In The Last Decade

Sakiko Sanada

27 papers receiving 493 citations

Peers

Countries citing papers authored by Sakiko Sanada

Since Specialization

Citations

This map shows the geographic impact of Sakiko Sanada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sakiko Sanada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sakiko Sanada more than expected).

Fields of papers citing papers by Sakiko Sanada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sakiko Sanada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sakiko Sanada. The network helps show where Sakiko Sanada may publish in the future.

Co-authorship network of co-authors of Sakiko Sanada

This figure shows the co-authorship network connecting the top 25 collaborators of Sakiko Sanada. A scholar is included among the top collaborators of Sakiko Sanada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sakiko Sanada. Sakiko Sanada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CXCR4 Expression and Cancer-associated Fibroblasts May Play an Important Role in the Invasion of Low-grade Endometrioid Carcinoma 2024 ·International Journal of Gynecological Pathology ·(unknown), Sakiko Sanada, Sachiko Ogasawara, Naotake Tsuda, Kenta Murotani, (unknown), Kimio Ushijima, Jun Akiba, Hirohisa Yano	0
2	The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study 2024 ·Gynecologic Oncology ·Paulette Mhawech‐Fauceglia, Denis M. McCarthy, Akiko Tonooka, Giovanni Scambia, Yolanda García García, Pavel Dundr, Anne M. Mills, Kathleen N. Moore, Sakiko Sanada, Leslie Bradford, G Stella, Michael A. Bookman, Sudarshan Sharma, Frédèric Selle, Luciana Molinero, (unknown), Victor K. Khor, Charles N. Landen, Yvonne G. Lin	2
3	Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters 2024 ·In Vivo ·Jun Akiba, Masamichi Nakayama, Reiichiro Kondo, Hironori Kusano, Sachiko Ogasawara, Yutaro Mihara, Masahiko Tanigawa, (unknown), (unknown), (unknown), (unknown), T. Mitsuhashi, (unknown), Sakiko Sanada, (unknown), Toru Hisaka, Hirohisa Yano	5
4	Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy 2023 ·The Kurume Medical Journal ·(unknown), Shin Nishio, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Naotake Tsuda, Sakiko Sanada, Kimio Ushijima	1
5	N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin 2022 ·The Kurume Medical Journal ·(unknown), Naotake Tsuda, (unknown), (unknown), (unknown), (unknown), (unknown), Shin Nishio, Tomohiko Yamaguchi, Sakiko Sanada, Jun Akiba, Michihiko Kuwano, Mayumi Ono, Kimio Ushijima	1
6	Expression and significance of laminin receptor in squamous cell carcinoma of the tongue 2021 ·Journal of Oral Pathology and Medicine ·(unknown), Jun Akiba, Sachiko Ogasawara, Reiichiro Kondo, Yoshiki Naito, Hironori Kusano, Sakiko Sanada, Tatsuyuki Kakuma, Jingo Kusukawa, Hirohisa Yano	3
7	Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget’s Disease 2021 ·Anticancer Research ·(unknown), Jun Akiba, Reiichiro Kondo, (unknown), Sachiko Ogasawara, Yoshiki Naito, Hironori Kusano, Sakiko Sanada, (unknown), Takekuni Nakama, Hirohisa Yano	6
8	Low-molecular-weight Protein Tyrosine Phosphatase Is a Possible Biomarker for Predicting Postoperative Biochemical Recurrence in Prostate Cancer With Negative Surgical Margins 2019 ·Anticancer Research ·Hirofumi Kurose, Kosuke Ueda, Reiichiro Kondo, Sachiko Ogasawara, Hironori Kusano, Sakiko Sanada, Yoshiki Naito, Jun Akiba, Tatsuyuki Kakuma, Tsukasa Igawa, Hirohisa Yano	4
9	High sulfite oxidase expression could predict postoperative biochemical recurrence in patients with prostate cancer 2019 ·Medical Molecular Morphology ·Hirofumi Kurose, Yoshiki Naito, Jun Akiba, Reiichiro Kondo, Sachiko Ogasawara, Hironori Kusano, Sakiko Sanada, Hideyuki Abe, Tatsuyuki Kakuma, Kosuke Ueda, Tsukasa Igawa, Hirohisa Yano	8
10	Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer 2019 ·Anticancer Research ·Hirofumi Kurose, Kosuke Ueda, Reiichiro Kondo, Sachiko Ogasawara, Hironori Kusano, Sakiko Sanada, Yoshiki Naito, Makoto Nakiri, Kiyoaki Nishihara, Tatsuyuki Kakuma, Jun Akiba, Tsukasa Igawa, Hirohisa Yano	20
11	A Case of Rectal Schwannoma Showing High Uptake on FDG-PET 2017 ·Nihon Daicho Komonbyo Gakkai Zasshi ·(unknown), Yoshito Akagi, (unknown), Tetsushi Kinugasa, Sakiko Sanada, (unknown)	0
12	The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type 2016 ·Journal of Clinical Pathology ·Jun Akiba, Osamu Nakashima, Satoshi Hattori, Yoshiki Naito, Hironori Kusano, Reiichiro Kondo, Masamichi Nakayama, Ken Tanikawa, (unknown), (unknown), Ken Nakamura, Sakiko Sanada, Rin Yamaguchi, Sachiko Ogasawara, Hirohisa Yano	21
13	Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells 2015 ·Acta Biomaterialia ·Kosuke Ueda, Jun Akiba, Sachiko Ogasawara, (unknown), Masamichi Nakayama, (unknown), Hironori Kusano, Sakiko Sanada, Shigetaka Suekane, Keming Xu, Ki Hyun Bae, Motoichi Kurisawa, Tsukasa Igawa, Hirohisa Yano	45
14	Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma 2015 ·PLoS ONE ·(unknown), Jun Akiba, Sachiko Ogasawara, Masamichi Nakayama, Yoriko Nomura, Makiko Yasumoto, Sakiko Sanada, Osamu Nakashima, Toshi Abe, Hirohisa Yano	15
15	Pegylated Interferon-α2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo 2013 ·PLoS ONE ·Hironori Kusano, Jun Akiba, Sachiko Ogasawara, Sakiko Sanada, Makiko Yasumoto, Masamichi Nakayama, Keiko Ueda, Kosuke Ueda, Takashi Kurita, (unknown), (unknown), Osamu Nakashima, Hirohisa Yano	17
16	Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line 2013 ·PLoS ONE ·Kosuke Ueda, Sachiko Ogasawara, Jun Akiba, Masamichi Nakayama, (unknown), Keiko Ueda, Sakiko Sanada, Shigetaka Suekane, Masanori Noguchi, Kei Matsuoka, Hirohisa Yano	78
17	Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification 2013 ·The American Journal of Surgical Pathology ·Jun Akiba, Osamu Nakashima, Satoshi Hattori, Ken Tanikawa, Miki Takenaka, (unknown), Reiichiro Kondo, Yoriko Nomura, Keiko Koura, (unknown), Sakiko Sanada, Yoshiki Naito, Rin Yamaguchi, Hirohisa Yano	112
18	RECQL1 DNA Repair Helicase: A Potential Therapeutic Target and a Proliferative Marker against Ovarian Cancer 2013 ·PLoS ONE ·Sakiko Sanada, Kazunobu Futami, (unknown), Koji Yonemoto, Sachiko Ogasawara, Jun Akiba, Makiko Yasumoto, (unknown), Kimio Ushijima, Toshiharu Kamura, Yasuhiro Furuichi, Hirohisa Yano	20
19	Malignant melanoma arising in a plaque‐type blue nevus 2012 ·Pathology International ·Sakiko Sanada, Koichi Higaki, (unknown), (unknown), Rin Yamaguchi, Yasuhiro Nakamura, Hirohisa Yano	18
20	N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase 2011 ·Cancer Letters ·Jun Akiba, Yûichi Murakami, Masaki Noda, Kosuke Watari, Sachiko Ogasawara, Takafumi Yoshida, Akihiko Kawahara, Sakiko Sanada, Makiko Yasumoto, Rin Yamaguchi, Masayoshi Kage, Michihiko Kuwano, Mayumi Ono, Hirohisa Yano	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact